Pharmaceutical Technology

FEBRUARY 15, 2023

The swift development and deployment of messenger-RNA (mRNA) vaccines against the SARS-CoV-2 virus during the COVID-19 crisis has catapulted the pharmaceuticals industry into a new paradigm. Another area where we tend to see problems is in encapsulation efficiency,” says Andrew Kondratowicz, Bioassay Team Lead, Precision NanoSystems.

Bioassay 130

Bioassay RNA Development Drugs 130

pharmaphorum

SEPTEMBER 26, 2022

As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4 th Annual Gene Therapy Analytical Development as an analytical scientist has never been so important. Download the full event guide to find out more.

Gene Therapy 52

Gene Therapy Gene Development Bioassay 52

pharmaphorum

AUGUST 5, 2021

The issue, however, is developing an effective way of targeting them. . Understanding the mechanism of PPIs and developing methods to target aberrant ones has been a key strategy in drug development. The flat interface remains the primary challenge facing the development of PPI modulators.

Protein 126

Protein Gene Bioassay DNA 126